San Francisco startup Hims & Hers took a further step into the mental health realm on Thursday, rolling out a new service that connects people with providers who can prescribe and manage common medications for depression and anxiety.
The new feature is part of a broader recent push by the company as it works to position itself as a full-service telemedicine provider. The company has capitalized on the boom in telehealth fueled by the Covid-19 pandemic and is exploring going public — which could bring a valuation of more than $1 billion, Reuters reported Wednesday.
The company plans to follow its medication service with more behavioral health offerings — including individual talk therapy — in the coming months, and is bringing on Julian Cohen, the former president of behavioral health at telemedicine giant Teladoc, to oversee the program.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect